Receptors for Insulin-Like Growth Factor-2 and Androgens as Therapeutic Targets in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) occurs in 10–15% of all breast cancer patients, yet it accounts for about half of all breast cancer deaths. There is an urgent need to identify new antitumor targets to provide additional treatment options for patients afflicted with this aggressive disease. Prec...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamilton, Nalo, Austin, David, Márquez-Garbán, Diana, Sanchez, Rudy, Chau, Brittney, Foos, Kay, Wu, Yanyuan, Vadgama, Jaydutt, Pietras, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5713274/
https://www.ncbi.nlm.nih.gov/pubmed/29099049
http://dx.doi.org/10.3390/ijms18112305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5713274/
https://www.ncbi.nlm.nih.gov/pubmed/29099049
http://dx.doi.org/10.3390/ijms18112305

Ejemplares similares